Simponi Works for Patients with AS, RA, and PsA – Even with Prior TNF Inhibitor Treatment
mohamed_hassan / Pixabay

Simponi Works for Patients with AS, RA, and PsA – Even with Prior TNF Inhibitor Treatment

  In some cases, people have a medical condition that doesn't respond well to treatments. The journey to finding an effective treatment can be long and difficult. But for patients…

Continue Reading Simponi Works for Patients with AS, RA, and PsA – Even with Prior TNF Inhibitor Treatment

A Subcutaneous Form of Remsima May be Available Soon in the EU

Celltrion Healthcare has just announced positive progress for extending the authorization for the subcutaneous (SC) form of Remsima to five more autoimmune conditions. These are- Psoriatic arthritis Ankylosing spondylitis (AS)…

Continue Reading A Subcutaneous Form of Remsima May be Available Soon in the EU

New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)

At this year's EULAR 2020 E-Congress, Dr. Suzanne Verstappen, MD, presented on how lifestyle changes could benefit patients with rheumatic and musculoskeletal diseases (RMDs). Her interest in the impact of…

Continue Reading New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)
FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
source: pixabay.com

FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis

In a press release from Eli Lilly and Company, the company has announced recently that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (BLA)…

Continue Reading FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
Ankylosing Spondylitis has Taken Her Mobility, and She Fears Her Daughter is Next
source: pixabay.com

Ankylosing Spondylitis has Taken Her Mobility, and She Fears Her Daughter is Next

For Emma, the worst part of receiving her diagnosis with ankylosing spondylitis wasn't adapting to the constant pain, losing her breath over five minutes of standing, being too exhausted to…

Continue Reading Ankylosing Spondylitis has Taken Her Mobility, and She Fears Her Daughter is Next
TNFi Treatment Ineffective for Some Patients with Ankylosing Spondylitis
jarmoluk / Pixabay

TNFi Treatment Ineffective for Some Patients with Ankylosing Spondylitis

  According to Ankylosing Spondylitis News, a recent study has found that TNF inhibitors are often not effective treatments for patients with ankylosing spondylitis. Read the full study in BMC Rheumatology.…

Continue Reading TNFi Treatment Ineffective for Some Patients with Ankylosing Spondylitis
Novartis Cosentyx® Receives Positive CHMP Opinion for Non-Radiographic Axial Spondyloarthritis Treatment
source: pixabay.com

Novartis Cosentyx® Receives Positive CHMP Opinion for Non-Radiographic Axial Spondyloarthritis Treatment

  According to a press release on Global Newswire, Novartis has received a positive opinion on Cosentyx® from the Committee for Medicinal Products for Human Use (CHMP). This positive opinion…

Continue Reading Novartis Cosentyx® Receives Positive CHMP Opinion for Non-Radiographic Axial Spondyloarthritis Treatment
Ankylosing Spondylitis: Most Patients Don’t Switch TNF Inhibitors, Even if They Stop Working
source: pixabay.com

Ankylosing Spondylitis: Most Patients Don’t Switch TNF Inhibitors, Even if They Stop Working

According to a story from Healio, a recent study that was published in the scientific journal BMC Rheumatology revealed that it was uncommon for patients living with ankylosing spondylitis to switch from…

Continue Reading Ankylosing Spondylitis: Most Patients Don’t Switch TNF Inhibitors, Even if They Stop Working
A Biosimilar Drug for Treating Rheumatoid Arthritis and Ankylosing Spondylitis Begins Phase 3 Trials
source: pixabay.com

A Biosimilar Drug for Treating Rheumatoid Arthritis and Ankylosing Spondylitis Begins Phase 3 Trials

According to a story from Acrofan, the biotechnology company Clover Pharmaceuticals Inc. has recently announced that the first patient has been dosed in its phase 3 clinical study. This study…

Continue Reading A Biosimilar Drug for Treating Rheumatoid Arthritis and Ankylosing Spondylitis Begins Phase 3 Trials
A Recent Trial Found the Drug Rinvoq Can be Effective Treatment for Ankylosing Spondylitis
source: pixabay.com

A Recent Trial Found the Drug Rinvoq Can be Effective Treatment for Ankylosing Spondylitis

According to a story from Ankylosing Spondylitis News, the results of a recent phase 2/3 clinical trial indicate that the drug upadacitinib (marketed as Rinvoq) can be an effective treatment…

Continue Reading A Recent Trial Found the Drug Rinvoq Can be Effective Treatment for Ankylosing Spondylitis
Is TNF Inhibitor Treatment Necessary for Ankylosing Spondylitis Patients in Remission?
qimono / Pixabay

Is TNF Inhibitor Treatment Necessary for Ankylosing Spondylitis Patients in Remission?

According to a story from The Rheumatologist, a common treatment method for ankylosing spondylitis, a form of rare arthritis the affects the sacroiliac joints and spine, is a class of…

Continue Reading Is TNF Inhibitor Treatment Necessary for Ankylosing Spondylitis Patients in Remission?
Results of Phase 3 Trial Suggest The Drug Cosentyx Could be Effective for Axial Spondyloarthritis
source: pixabay.com

Results of Phase 3 Trial Suggest The Drug Cosentyx Could be Effective for Axial Spondyloarthritis

According to a story from Ankylosing Spondylitis News, findings from a phase 3 clinical trial suggest that the drug secukinumab (marketed as Cosentyx) could be an effective treatment for non-radiographic…

Continue Reading Results of Phase 3 Trial Suggest The Drug Cosentyx Could be Effective for Axial Spondyloarthritis
Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
stevepb / Pixabay

Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA

According to a story from Ankylosing Spondylitis News, the drug Hadlima, which is a biosimilar to the drug Humira (adalimumab), was recently approved by the US Food and Drug Administration…

Continue Reading Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
New Research Suggests “Nonsense” RNA Segment Might Play Important Role in Ankylosing Spondylitis
Source: Pixabay

New Research Suggests “Nonsense” RNA Segment Might Play Important Role in Ankylosing Spondylitis

According to a publication from Ankylosing Spondylitis News, a recent study published in BMC Musculoskeletal Disorders suggests that LINC00311, a lengthy RNA molecule, is over-expressed in individuals with ankylosing spondylitis.…

Continue Reading New Research Suggests “Nonsense” RNA Segment Might Play Important Role in Ankylosing Spondylitis
Recent Study Finds Better Than Expected Safety Data for TNF Inhibitors in Ankylosing Spondylitis
skeeze / Pixabay

Recent Study Finds Better Than Expected Safety Data for TNF Inhibitors in Ankylosing Spondylitis

According to a story from Ankylosing Spondylitis News, a recent study has found that the class of drugs known as tumor necrosis factor (TNF) inhibitors may actually be safer for…

Continue Reading Recent Study Finds Better Than Expected Safety Data for TNF Inhibitors in Ankylosing Spondylitis

ICYMI: A Good Business Decision vs. The Right Ethical Choice: Conducting Clinical Trials

A recent article written by Craig Klugman debates the ethical obligations pharmaceutical companies have to conduct clinical trials for drugs which have a likely potential to benefit a patient population…

Continue Reading ICYMI: A Good Business Decision vs. The Right Ethical Choice: Conducting Clinical Trials

Each Ankylosing Spondylitis Patient is Unique, This Study Reinforces that to Provide the Best Care, We Must Understand That

A New AS Study A recent study, published in Reumatologia aimed to evaluate how ankylosing spondylitis (AS) patients are coping with their condition on a psychological level. They wanted to investigate…

Continue Reading Each Ankylosing Spondylitis Patient is Unique, This Study Reinforces that to Provide the Best Care, We Must Understand That

Finding Unbiased, Credible Information About Your Rare Disease Can Be Difficult, This Compilation of Resources May Help

When you or your child is first diagnosed with a rare disease it can be so difficult to know where to turn. You want to learn everything about the condition,…

Continue Reading Finding Unbiased, Credible Information About Your Rare Disease Can Be Difficult, This Compilation of Resources May Help
Study Finds That Older Female Ankylosing Spondylitis Patients with Dyslipidemia are at Greater Risk of Osteoporosis
rawpixel / Pixabay

Study Finds That Older Female Ankylosing Spondylitis Patients with Dyslipidemia are at Greater Risk of Osteoporosis

According to a story from Ankylosing Spondylitis News, a recent study has reaffirmed the understanding that patients with ankylosing spondylitis, a rare form of inflammatory disease that affects the joints…

Continue Reading Study Finds That Older Female Ankylosing Spondylitis Patients with Dyslipidemia are at Greater Risk of Osteoporosis
Over 50% of Ankylosing Spondylitis Patients Relapse After Halting Infliximab, Study Claims
mohamed_hassan / Pixabay

Over 50% of Ankylosing Spondylitis Patients Relapse After Halting Infliximab, Study Claims

According to a story from Healio, a recent study has found that 58 percent of patients with the inflammatory disease ankylosing spondylitis will experience relapse within one year after stopping…

Continue Reading Over 50% of Ankylosing Spondylitis Patients Relapse After Halting Infliximab, Study Claims
Close Menu